m+Medelevator.RU
← Поиск публикаций
Scientific reports · 2026

Biosynthesis of zinc oxide nanoparticles and evaluation of anticancer activity against MCF-7 breast cancer cell line via phyto-synthesised nanoparticles.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Tanwar Shruti N, Parauha Yatish R, There Yogesh, Pethe Anil M, Dhoble S J

Аннотация

The present research work aims to biosynthesize ZnO nanoparticles using plant-mediated extracts (A. marmleos, A. indica and a mixture of both extracts) and to evaluate their physiochemical properties and associated biological activities. Transmission electron microscopy (TEM) analysis revealed that the majority of ZnO nanoparticles were spherical, uniformly distributed, and exhibited an average size within the nanometer scale. Photosynthesised ZnO NPs were characterized with particular emphasis on zeta potential, a key parameter influencing nanoparticle stability and biological interactions and its correlation with cytotoxic efficiency. Anticancer potential was assessed in vitro against the MCF-7 human breast cancer cell line, revealing dose-dependent inhibition of cancer cell proliferation with IC50 values closely associative reactive oxygen species (ROS) generation, mitochondrial membrane disruption, and induction of apoptosis. The nanoparticle demonstrated significantly antimicrobial activity against Gram-positive bacteria and indicated potential antioxidant properties through the scavenging of DPPH and H2O2, attributed to bioactive plant-derived surface capping agents. The finding indicates a significant correlation between the surface characteristics of nanoparticles and their biological efficiency. This indicates that ZnO NPs synthesised from plant extracts may have potential applications in various biomedical applications.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты